Related Experiment Video
Updated: Nov 2, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Risk of Cardiovascular Complications in Patients with Persistent Atrial Fibrillation after Dissolution of a Thrombus
E S Mazur1, V V Mazur1, N D Bazhenov1
1Tver State Medical University, Tver.
Insights
Patients with persistent atrial fibrillation (AF) and resolved left atrial appendage (LAA) thrombi face a significantly higher risk of cardiovascular complications (CVC) compared to those without LAA thrombosis. This includes increased risks of stroke and myocardial infarction.
Area of Science:
- Cardiology
- Vascular Medicine
- Thrombosis Research
Background:
- Persistent atrial fibrillation (AF) is associated with an increased risk of thromboembolic events.
- Left atrial appendage (LAA) thrombosis is a known complication in AF patients.
- Understanding the long-term cardiovascular risk after LAA thrombus resolution is crucial for patient management.
Purpose of the Study:
- To compare the incidence of cardiovascular complications (CVC) in patients with persistent AF following left atrial appendage (LAA) thrombus dissolution versus those without LAA thrombosis.
- To assess the specific risks of ischemic stroke, myocardial infarction (MI), and other adverse outcomes in these patient groups.
Main Methods:
- A cohort study comparing 43 patients with resolved LAA thrombosis (main group) to 123 patients without LAA thrombosis (control group), stratified by CHA2DS2‑VASc score.
- Transesophageal echocardiography was used for LAA thrombosis diagnosis and monitoring.
- Follow-up duration was approximately 47.3 months, recording all-cause mortality, stroke, bleeding, and MI.
Main Results:
- The main group experienced significantly higher rates of unfavorable clinical outcomes (39.5% vs. 3.3%, p<0.001).
- Higher incidence of ischemic stroke (RR, 12.9) and myocardial infarction (MI) (RR, 5.72) was observed in the main group.
- Stroke incidence rapidly increased in the first year post-thrombus dissolution.
Conclusions:
- Patients with persistent AF and resolved LAA thrombi have a substantially elevated risk of CVC.
- The findings underscore the need for vigilant monitoring and potentially intensified anticoagulation strategies in patients with a history of LAA thrombosis.
Abstract:
Aim To compare the incidence of cardiovascular complications (CVC) in patients with persistent atrial fibrillation (AF) following thrombus dissolution in the left atrial appendage (LAA) and in patients with persistent AF without preceding LAA thrombosis.Material and methods The main group included 43 patients who had been diagnosed with LAA thrombosis on the first examination, transesophageal echocardiography, and who showed dissolution of the thrombus on a repeated study performed after 7.1+2.0 weeks of the anticoagulant treatment. The control group consisted of 123 patients with a risk score >0 for men without LAA thrombosis and score >1 for women without LAA thrombosis according to the CHA2DS2‑VASc scale. The patients were followed up for 47.3±17.9 months. The following unfavorable outcomes were recorded: all-cause mortality, ischemic stroke or systemic thromboembolism, hemorrhagic stroke or severe bleeding, and myocardial infarction (MI).Results Unfavorable clinical outcomes were observed in 39.5 % of patients in the main group and in 3.3 % of patients in the control group (p<0.001). Furthermore, the incidence of ischemic stroke (relative risk (RR), 12.9; 95 % confidence interval (CI), 2.89-57.2), and MI (RR, 5.72; 95 % CI, 1.09-30.1) was higher in the main group. However, the number of MI cases in both groups and the number of stroke cases in the control group increased during the entire follow-up period, while the number of stroke cases rapidly increased only during the first year of follow-up.Conclusion In patients with persistent AF, the risk of CVC after LAA thrombus dissolution remains significantly higher than in patients with AF without LAA thrombosis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization II: Right Heart Catheterization

